Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects
Metadata
Show full item recordAuthor
Sánchez Diaz, Manuel; López Delgado, David; Montero Vílchez, Trinidad; Salvador Rodríguez, Luis; Molina Leyva, Alejandro; Tercedor Sánchez, Jesús; Arias Santiago, Salvador AntonioEditorial
MDPI
Materia
Minoxidil Hypertrichosis Alopecia Children
Date
2021-09-20Referencia bibliográfica
Sánchez-Díaz, M... [et al.]. Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects. J. Clin. Med. 2021, 10, 4257. [https://doi.org/10.3390/jcm10184257]
Abstract
Oral minoxidil is an approved treatment for high blood pressure which is also used as
an off-label drug for alopecia. Knowledge about the effects of systemic minoxidil in the paediatric
population is limited. A retrospective case series study of paediatric patients with history of systemic
minoxidil intake due to contaminated sets of omeprazole was performed to describe side effects of
high dose oral minoxidil intake in children. Twenty patients aged between 2 months and 13 years
joined the study. They had received high doses of oral minoxidil (mean dose 0.90 mg/kg/day)
during a mean time of 38.3 days. Hypertrichosis appeared in 65%, with a mean latency time of
24.31 days. Treatment time was associated with the appearance of hypertrichosis (p < 0.05). Most
common initial zone of hypertrichosis was the face. Systemic effects developed in 15%, with no cases
of severe disorders. The present study shows a novel insight into the side effects of high doses of oral
minoxidil in children.